PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations

Pinnacle Health Fox Chase Regional Cancer Center, Harrisburg

Bux-Mont Oncology Hematology Associates (FCCC) at Grand View Hospital, Sellersville

Virginia Oncology Associates, Norfolk

HOPE a Women's Cancer Center, Asheville

Memorial Cancer Institute Breast Cancer Center, Hollywood

University of Miami, Sylvester Comprehensive Cancer Center, Miami

The West Clinic, Memphis

Seidman Cancer Center, Cleveland

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis

Community Regional Cancer Center, Indianapolis

Monroe Medical Associates, Munster

Northern Indiana Cancer Research Consortium, South Bend

Fort Wayne Oncology & Hematology, Inc, Fort Wayne

Horizon Oncology Research, Inc./IU Health Arnett, Lafayette

Metro Health Cancer Care, Wyoming

Siteman Cancer Center, St Louis

University of Colorado Cancer Center, Aurora

Presbyterian Medical Group, Albuquerque

University of New Mexico Cancer Center: Albuquerque, Albuquerque

Comprehensive Cancer Centers of Nevada, Las Vegas

University of California Los Angeles, Los Angeles

St. Jude Heritage Healthcare, Fullerton

Central Coast Medical Oncology Corporation, Santa Maria

Oregon Health Sciences University, Portland

The Center for Cancer & Hematologic Disease, Cherry Hill

Virtua Health Cancer Program, Mount Holly

South Jersey Health Care, Vineland